These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30419006)

  • 1. Correction: Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(11):e0207561. PubMed ID: 30419006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin.
    Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK
    J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anti-ulcer agents and the risk of chronic kidney disease: a meta-analysis.
    Sun J; Sun H; Cui M; Sun Z; Li W; Wei J; Zhou S
    Int Urol Nephrol; 2018 Oct; 50(10):1835-1843. PubMed ID: 29948864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.
    Schneider MP; Hilgers KF; Schmid M; Hübner S; Nadal J; Seitz D; Busch M; Haller H; Köttgen A; Kronenberg F; Baid-Agrawal S; Schlieper G; Schultheiss U; Sitter T; Sommerer C; Titze S; Meiselbach H; Wanner C; Eckardt KU;
    PLoS One; 2018; 13(9):e0204340. PubMed ID: 30212585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton pump inhibitors and kidney].
    Desbuissons G; Deray G; Mercadal L
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S115-S124. PubMed ID: 29274872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Investigating the Proton Donor in the NO Reductase from Paracoccus denitrificans.
    PLOS ONE Staff
    PLoS One; 2016; 11(5):e0155365. PubMed ID: 27203242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.
    Kuwabara M; Hisatome I; Roncal-Jimenez CA; Niwa K; Andres-Hernando A; Jensen T; Bjornstad P; Milagres T; Cicerchi C; Song Z; Garcia G; Sánchez-Lozada LG; Ohno M; Lanaspa MA; Johnson RJ
    PLoS One; 2018; 13(5):e0197941. PubMed ID: 29772014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology.
    Schley G; Jordan J; Ellmann S; Rosen S; Eckardt KU; Uder M; Willam C; Bäuerle T
    PLoS One; 2019; 14(6):e0218876. PubMed ID: 31216339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients.
    Yang H; Juang SY; Liao KF
    Diabetes Res Clin Pract; 2019 Jan; 147():67-75. PubMed ID: 30500543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Evaluation of biochemical profile of Chronic Kidney Disease of uncertain etiology in Sri Lanka.
    Fernando BNTW; Sudeshika T; Hettiarachchi TW; Badurdeen Z; Abeysekara TDJ; Abeysundara HTK; Jayasinghe S; Ranasighe S; Nanayakkara N
    PLoS One; 2020; 15(8):e0238279. PubMed ID: 32817721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.